| Period Ending: |
LTM
(Last Twelve Months) |
2022 12-31 |
2021 12-31 |
|---|---|---|---|
| Report Filing | 2023-05-15 | 2023-03-31 | 2022-03-31 |
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 |
| Operating Expenses | 2.51 | 1.22 | 0.57 |
| Research & Development | 0 | 0 | 0 |
| Selling, General and Administrative | 2.35 | 1.02 | 0.395 |
| Other Operating Expenses | 0.165 | 0.2 | 0.175 |
| Operating Income | -2.51 | -1.22 | -0.57 |
| Net Non-Operating Interest | 3.42 | 2.09 | 0 |
| Interest Income | 3.42 | 2.09 | 0 |
| Interest Expense | 0.002 | 0 | 0 |
| Equity & Other Income/(Expense) | 3.25 | 6.38 | 0.57 |
| Income Before Tax | 4.16 | 7.25 | 0 |
| Income Tax Expense | -1.7 | 0.36 | 0 |
| Income Attributable to Non-Controlling Interest | -0.001 | 0 | 0 |
| Net Income | 5.86 | 6.89 | 0 |
| Depreciation and Amortization | -2.94 | -6.38 | 0.237 |
| EBITDA | -5.46 | -7.59 | -0.333 |
| Earnings Per Share (EPS) | 0.94 | 0.46 | 0 |
| Diluted Earnings Per Share | 0.556 | 0.46 | 0 |
| Weighted Average Shares Outstanding | 8.95 | 15 | 18.75 |
| Diluted Weighted Average Shares Outstanding | 12.7 | 15 | 18.75 |
